Delink drug prices from R&D costs: UN

The United Nations High-Level Panel on Access to Medicines has called for delinking drug prices from research and development (R&D) costs. The report submitted by panel calls for human rights to be placed over intellectual property laws of pharmaceutical companies ..

Month: Current Affairs - September, 2016